World's Best Scientists 2026 revealed!
Yves Levy

Yves Levy

D-Index & Metrics

Immunology

D-Index
69
Citations
22878
World Ranking
2475
National Ranking
102

Yves Levy publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Yves Levy sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 342 publications — 72nd percentile

72% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Yves Levy D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Yves Levy sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 69 D-Index — 50th percentile

50% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Yves Levy is affiliated with Grenoble Alpes University in France and has a significant body of research primarily in Medicine and Immunology and Microbiology. Their work spans various subfields, including Infectious Diseases, Immunology, Molecular Biology, Virology, and Epidemiology.

The research topics addressed by Yves Levy include:

  • SARS-CoV-2 and COVID-19 Research
  • Immunotherapy and Immune Responses
  • COVID-19 Clinical Research Studies
  • HIV Research and Treatment
  • Vaccines and Immunoinformatics Approaches
  • T-cell and B-cell Immunology
  • Viral Infections and Outbreaks Research

Yves Levy has contributed to numerous publications, with recent noteworthy papers including:

  • Safety and immunogenicity of a two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Europe (EBOVAC2): a randomised, observer-blind, participant-blind, placebo-controlled, phase 2 trial (2020), published in The Lancet Infectious Diseases
  • The cytokines HGF and CXCL13 predict the severity and the mortality in COVID-19 patients (2021), published in Nature Communications
  • Asymptomatic and symptomatic SARS-CoV-2 infections elicit polyfunctional antibodies (2021), published in Cell Reports Medicine
  • Vaccine Inoculation Route Modulates Early Immunity and Consequently Antigen-Specific Immune Response (2021), published in Frontiers in Immunology
  • Long-lasting severe immune dysfunction in Ebola virus disease survivors (2020), published in Nature Communications

Frequent coauthors of Yves Levy include:

  • Aurélie Wiedemann
  • Christine Lacabaratz
  • Rodolphe Thiébaut
  • Mathieu Surénaud
  • Jean-Daniel Lelièvre

The main venues where Yves Levy publishes are:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Frontiers in Immunology
  • The Journal of Immunology
  • Nature Communications
  • PLoS Pathogens

Best Publications

  • Circulating microRNAs in sera correlate with soluble biomarkers of immune activation but do not predict mortality in ART treated individuals with HIV-1 infection : a case control study

    Daniel D. Murray;Kazuo Suzuki;Matthew Law;Jonel Trebicka

  • Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the Hyper-IgM syndrome (HIGM2).

    Patrick Revy;Taro Muto;Yves Levy;Frédéric Geissmann

  • Role of interleukin 10 in the B lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosus.

    Luis Llorente;Weiping Zou;Yves Levy;Yvonne Richaud-Patin

  • Human immunodeficiency virus-driven expansion of CD4+CD25+ regulatory T cells, which suppress HIV-specific CD4 T-cell responses in HIV-infected patients.

    Laurence Weiss;Vladimira Donkova-Petrini;Laure Caccavelli;Michèle Balbo

  • Interleukin-2 therapy in patients with HIV infection.

    D. Abrams;Y. Lévy;M. H. Losso;A. Babiker

  • Mutations of CD40 gene cause an autosomal recessive form of immunodeficiency with hyper IgM

    Simona Ferrari;Silvia Giliani;Antonella Insalaco;Abdulaziz Al-Ghonaium

  • Enhanced T cell recovery in HIV-1–infected adults through IL-7 treatment

    Yves Levy;Christine Lacabaratz;Laurence Weiss;Jean-Paul Viard

  • HIV-1 Tat Assembles a Multifunctional Transcription Elongation Complex and Stably Associates with the 7SK snRNP

    Bijan Sobhian;Nadine Laguette;Ahmad Yatim;Mirai Nakamura

  • Interleukin-10 prevents spontaneous death of germinal center B cells by induction of the bcl-2 protein.

    Unknown

  • Neuronal apoptosis in HIV infection in adults.

    H. Adle-Biassette;Y. Levy;M. Colornbel;F. Poron

  • Effects of Recombinant Human Interleukin 7 on T-Cell Recovery and Thymic Output in HIV-Infected Patients Receiving Antiretroviral Therapy: Results of a Phase I/IIa Randomized, Placebo-Controlled, Multicenter Study

    Y. Lévy;I. Sereti;G. Tambussi;J. P. Routy

  • NOTCH1 Nuclear Interactome Reveals Key Regulators of Its Transcriptional Activity and Oncogenic Function

    Ahmad Yatim;Clarisse Benne;Bijan Sobhian;Sabine Laurent-Chabalier

  • Genomewide Association Study of an AIDS-Nonprogression Cohort Emphasizes the Role Played by HLA Genes (ANRS Genomewide Association Study 02)

    Sophie Limou;Sigrid Le Clerc;Sigrid Le Clerc;Cédric Coulonges;Cédric Coulonges;Wassila Carpentier

  • CD32a is a marker of a CD4 T-cell HIV reservoir harbouring replication-competent proviruses

    Benjamin Descours;Gaël Petitjean;José-Luis López-Zaragoza;José-Luis López-Zaragoza;Timothée Bruel;Timothée Bruel

  • Autoimmune thrombocytopenic purpura and common variable immunodeficiency: analysis of 21 cases and review of the literature.

    Marc Michel;Valérie Chanet;Lionel Galicier;Marc Ruivard

  • Treatment of aggressive multiple myeloma by high-dose chemotherapy and total body irradiation followed by blood stem cells autologous graft

    Jean-Paul Fermand;Yves Levy;Jean Gerota;Marc Benbunan

  • Role of miR-155 in the regulation of lymphocyte immune function and disease

    Nabila Seddiki;Nabila Seddiki;Vedran Brezar;Vedran Brezar;Nicolas Ruffin;Nicolas Ruffin;Yves Lévy;Yves Lévy

  • CD39/Adenosine Pathway Is Involved in AIDS Progression

    Maria Nikolova;Matthieu Carriere;Mohammad Ali Jenabian;Sophie Limou;Sophie Limou

  • Comparison of subcutaneous and intravenous interleukin-2 in asymptomatic HIV-1 infection : a randomised controlled trial

    Y Levy;C Capitant;S Houhou;I Carriere

  • Common variable immunodeficiency is associated with defective functions of dendritic cells.

    Jagadeesh Bayry;Sébastien Lacroix-Desmazes;Michel D. Kazatchkine;Lionel Galicier

  • Immunological efficacy of a prime-boost pneumococcal vaccination in HIV-infected adults.

    Philippe Lesprit;Gaëlle Pédrono;Jean-Michel Molina;Cécile Goujard

  • Interleukin-6 antisense oligonucleotides inhibit the growth of human myeloma cell lines.

    Yves Levy;Andreas Tsapis;Jean-Claude Brouet

Frequent Co-Authors

Gerard Zurawski
Gerard Zurawski Baylor University
Rodolphe Thiébaut
Rodolphe Thiébaut University of Bordeaux
Jean-François Delfraissy
Jean-François Delfraissy National Ethical Consultative Committee for Life Sciences and Health
Geneviève Chêne
Geneviève Chêne University of Bordeaux
Giuseppe Pantaleo
Giuseppe Pantaleo University of Lausanne
Sandra Zurawski
Sandra Zurawski Baylor University
Cécile Goujard
Cécile Goujard University of Paris-Saclay
Jean-Claude Brouet
Jean-Claude Brouet Grenoble Alpes University
Laurence Weiss
Laurence Weiss Université Paris Cité

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, expanding your expertise through related healthcare degrees can unlock diverse career opportunities. Nursing roles, for example, often intersect with immunological knowledge, especially in specialties like psychiatric mental health or acute care. Exploring the cheapest pmhnp programs online can be a cost-effective way to enter a niche that combines mental health with immunological conditions.

Many professionals look to advance their clinical practice and income potential by specializing. The report on the highest paid dnp specialties reveals lucrative options, including nurse practitioner roles where immunology intersects with acute patient care.

Transitioning from a family nurse practitioner to a more specialized role is possible through targeted curricula. If you are considering this path, reviewing acute care nurse practitioner programs offers guidance on how to build relevant skills quickly and effectively.

For those eager to accelerate their nursing careers, accelerated nurse practitioner program options provide flexible online formats that complement studies in Immunology and allow faster entry into advanced practice roles.

Best Scientists Citing Yves Levy

Trending Scientists

Recently Published Articles